INVASIVE MOLE HYDATIFORM : CASE REPORT AND REVIEW OF THE LITERATURE

Volume: 44 Number: 2 June 1, 2005
  • Mustafa Cosan Terek
  • Levent Akman
  • Osman Zekioglu
  • Yılmaz Dikmen
  • Yıldız Erhan
  • Mustafa Ulukuş
Ege Journal of Medicine Cover
Ege Journal of Medicine
PDF Download
EN TR

INVASIVE MOLE HYDATIFORM : CASE REPORT AND REVIEW OF THE LITERATURE

Abstract

Although invasive mole is seen in fertil young women rarely, because of fatal outcomes it is important to treat it rapidly. We presented 37-year-old and 42 –year-old patient with vaginal bleeding after endometrial curettage and 25-year-old patient who has a continuous high level of human chorionic gonadotropin (hCG) after endometrial curettage. We diagnosed invasive mole and performed chemotherapy. We performed hysterectomy to the two patients who completed the parity and follow-up of the patient which hCG value is negative and wishes to preserve fertility. After molar pregnancy curratege, 15-20% patients can develop postmolar gestational trophoblastic diseaes . The vaginal bleeding that continues after molar pregnancy curettage, high or not decrease value of hCG and the persistant theca lutein cysts are the most frequency findigs. The patients must be researched for metastasis. Usually, after curettage chemotherapy is necessary and sometimes hysterectomy can be done.

Keywords

Details

Primary Language

Turkish

Subjects

-

Journal Section

-

Authors

Mustafa Cosan Terek

Levent Akman

Osman Zekioglu

Yılmaz Dikmen

Yıldız Erhan

Mustafa Ulukuş

Publication Date

June 1, 2005

Submission Date

June 1, 2005

Acceptance Date

-

Published in Issue

Year 2005 Volume: 44 Number: 2

IZ

https://izlik.org/JA35RU72BX

Cite

RIS / Bibtex
Vancouver
1.Mustafa Cosan Terek, Levent Akman, Osman Zekioglu, Yılmaz Dikmen, Yıldız Erhan, Mustafa Ulukuş. İNVAZİV MOL HİDATİDİFORM : OLGU SUNUMU VE LİTERATÜR DERLEMESİ. EJM [Internet]. 2005 Jun. 1;44(2):127-30. Available from: https://izlik.org/JA35RU72BX

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.